q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

May 2024 Drug List Updates: Thirty-seven (37) new generic drugs added to many Medicare Part D plan formularies.

Category: Monthly Formulary changes
Published: Jun, 02 2024 10:06:52
< Previous
Next >
As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the May 2024 Medicare Part D formulary updates included fifty-two (52) new drugs, thirty-seven (37) of which are generics - with a total of seventy-five (75) new generic equivalents (variations of manufacturer, drug-strength, and packaging).

Of the thirty-seven (37) new generic medications, ten (10) are newly-introduced generic drugs.  These new generic drugs include:
  • AMETHIA [Simpesse®],
  • BISOPROLOL FUMARATE [Zebeta®],
  • BROMFENAC SOD [BromSite®],
  • CETIRIZINE HCL [Zyrtec Syrup®],
  • CYCLOSERINE [Seromycin®],
  • DEFLAZACORT [Emflaza®],
  • HEATHER [Sharobel 28-Day®],
  • LOTEPREDNOL ETABONATE [Alrex®],
  • MIFEPRISTONE [Korlym®], and
  • TRIENTINE HCL®].

Please note that these new generic drugs are not available on all Medicare Part D (PDP) or Medicare Advantage plan (MAPD) formularies.  You can review the chart below to see the (often limited) number of plan formularies that now include these drugs.



Generic Drug Equivalent [Brand-Name Drug]

Number of
PDP
Formularies*

Number of
MAPD
Formularies*
ADALIMUMAB-AACF(CF) PEN 40 MG PEN IJ KIT [Idacio] 2 27
ALYQ 20 MG TABLET [Cialis] 28 252
AMETHIA 0.15-0.03-0.01 MG TABLET TBDSPK 3MO [Simpesse] 27 217
AMPICILLIN-SULBACTAM 15 GM VIAL [Unasyn] 38 339
AZATHIOPRINE 50 MG TABLET [Imuran] 54 369
BETAMETHASONE DP AUG 0.05% OINTMENT [Diprolene] 54 364
BISOPROLOL FUMARATE 10 MG TABLET [Zebeta] 54 368
BISOPROLOL FUMARATE 5 MG TABLET [Zebeta] 54 368
BISOPROLOL-HCTZ 2.5-6.25 MG TABLET [Ziac] 52 368
BISOPROLOL-HCTZ 5-6.25 MG TABLET [Ziac] 52 368
BRIMONIDINE 0.2% EYE DROPS [Alphagan] 54 369
BROMFENAC SOD 0.075% EYE DROPS [BromSite] 2 85
BUPRENORPHINE 10 MCG/HR PATCH [Butrans] 15 216
BUPRENORPHINE 15 MCG/HR PATCH [Butrans] 15 216
BUPRENORPHINE 2 MG TABLET SUBLIGUAL [Subutex] 54 369
BUPRENORPHINE 20 MCG/HR PATCH [Butrans] 15 216
CEFUROXIME AXETIL 500 MG TABLET [Ceftin] 54 369
CETIRIZINE HCL 1 MG/ML SOLUTION [Zyrtec Syrup] 28 216
CICLOPIROX 0.77% CREAM (G) [Loprox] 53 368
CIPROFLOXACIN 0.3% EYE DROPS [Ciloxan] 54 369
CLONIDINE HCL ER 0.17 MG TABLET 24H 0 4
CLORAZEPATE 7.5 MG TABLET [Tranxene T-Tab] 54 368
CLOTRIMAZOLE 10 MG TROCHE [Mycelex Troche] 54 369
COLCHICINE 0.6 MG TABLET [Colcrys] 53 367
CYCLOSERINE 250 MG CAPSULE [Seromycin] 17 91
DABIGATRAN ETEXILATE 110 MG CAPSULE [Pradaxa] 32 170
DABIGATRAN ETEXILATE 150 MG CAPSULE [Pradaxa] 44 269
DABIGATRAN ETEXILATE 75 MG CAPSULE [Pradaxa] 44 269
DALFAMPRIDINE ER 10 MG TABLET 12H [Ampyra] 54 369
DEFLAZACORT 18 MG TABLET [Emflaza] 0 15
DEFLAZACORT 30 MG TABLET [Emflaza] 0 15
DEFLAZACORT 36 MG TABLET [Emflaza] 0 15
DEFLAZACORT 6 MG TABLET [Emflaza] 0 15
DESVENLAFAXINE SUCCNT ER 100MG TABLET 24H [Pristiq] 54 369
DEXTROAMP-AMPHET ER 20 MG CAPSULE 24H [Adderall XR] 50 334
DEXTROAMP-AMPHET ER 30 MG CAPSULE 24H [Adderall XR] 50 334
DOFETILIDE 250 MCG CAPSULE [Tikosyn] 54 369
DOFETILIDE 500 MCG CAPSULE [Tikosyn] 54 369
EC-NAPROXEN DR 500 MG TABLET [EC-Naprosyn] 50 328
ECONAZOLE NITRATE 1% CREAM (G) [Spectazole] 30 281
ENOXAPARIN 40 MG/0.4 ML SYRINGE [Lovenox] 54 369
ERTAPENEM 1 GRAM VIAL [Invanz] 54 369
ESTRADIOL 0.01% CREAM/APPL [Estrace] 54 368
ESTRADIOL 0.05 MG PATCH (2/WK) PATCH TDSW [Vivelle-Dot] 48 350
FENOFIBRIC ACID DR 135 MG CAPSULE [Trilipix] 27 289
GABAPENTIN 300 MG CAPSULE [Neurontin] 54 369
HALOPERIDOL DEC 100 MG/ML VIAL [Haldol Decanoate] 54 366
HEATHER 0.35 MG TABLET [Sharobel 28-Day] 41 221
INDOMETHACIN 25 MG/5 ML ORAL SUSPENSION [Indocin] 0 3
IPRATROPIUM 0.03% SPRAY [Atrovent] 54 369
IPRATROPIUM 0.06% SPRAY [Atrovent] 54 369
LACOSAMIDE 200 MG TABLET [Vimpat] 54 369
LOTEPREDNOL ETABONATE 0.2% DRP EYE DROPPER [Alrex] 9 88
LOTEPREDNOL ETABONATE 0.5% DRP EYE DROPPER [Lotemax] 14 181
METFORMIN HCL 1,000 MG TABLET [Glucophage] 54 369
METHYLPHENIDATE ER 36 MG TABLET 24H [RELEXXII] 8 161
METHYLPHENIDATE ER 54 MG TABLET 24H [RELEXXII] 8 161
MIFEPRISTONE 300 MG TABLET [Korlym] 41 239
NEBIVOLOL 10 MG TABLET [Bystolic] 40 352
NEBIVOLOL 2.5 MG TABLET [Bystolic] 40 352
NEBIVOLOL 20 MG TABLET [Bystolic] 40 352
NEBIVOLOL 5 MG TABLET [Bystolic] 40 352
PALIPERIDONE ER 3 MG TABLET 24H [Invega] 54 369
PALIPERIDONE ER 6 MG TABLET 24H [Invega] 54 369
POTASSIUM CL ER 8 MEQ CAPSULE ER [Micro-K Extencaps] 52 366
PREGABALIN 100 MG CAPSULE [Lyrica] 54 369
RISEDRONATE SODIUM 150 MG TABLET [Actonel] 17 322
SILDENAFIL 20 MG TABLET [Revatio] 54 369
SODIUM CHLORIDE 0.9% IV SOLUTION 54 369
TESTOSTERONE CYP 200 MG/ML VIAL [Virilon] 54 365
TOLTERODINE TART ER 2 MG CAPSULE 24H [Detrol LA] 51 363
TOLTERODINE TART ER 4 MG CAPSULE 24H [Detrol LA] 51 363
TRIENTINE HCL 500 MG CAPSULE 11 87
TROSPIUM CHLORIDE ER 60 MG CAPSULE 24H [Sanctura XR] 8 213
VILAZODONE HCL 40 MG TABLET [VIIBRYD] 54 366




*The number of formularies counts the unique formularies that offer this medication. As a note, the same formulary can be used by one or many different Medicare Part D plans. The same formulary can be used by both PDP and MAPD plans.

What Could the Addition of New Generic Drugs Mean to You?

  • You may be able to save money by switching from the brand-name drug to its generic equivalent – with your prescriber’s approval and a new prescription. Please note, you will need to look carefully at coverage costs as we have found that many generics are being offered on the same tier as their brand-name equivalent or the generics do not have a significantly lower retail price.

  • Your brand-name drug may no longer be available if a generic is now available. Based on past experience, you may find that many Medicare Part D plans discontinue coverage for the brand-name drug in the months following the introduction of the generic equivalent - or your plan may immediately drop the brand-name drug now that the generic is being introduced.

    If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you must continue taking the brand-name drug, you will need to ask your plan for a formulary exception to continue coverage for your brand-name drug.

    You can click for a chart showing the trends in formulary coverage for some of the more popular Medicare drugs and their generic equivalents.
As a note, both our Formulary Browser (you can view all the drugs covered by a single Medicare prescription drug plan) and our Q1Rx Drug Finder (you can view all the Medicare drug plans covering a single drug) have been updated with the May 2024 Medicare Part D formulary data.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
June 2024, May 2024, April 2024, September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
June 2024, September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
May 2024, June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting your Medicare plan
Star Ratings & plan quality
Annual Medicare plan changes
Enrollment topics
Late Enrollment Penalty (LEP)
Your Formulary (Drug List)
Monthly Formulary changes
Your Medicare plan coverage
Pharmacies & Providers
Changing Medicare plans
Special Enrollment Periods (SEPs)
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and high costs
Out-of-Pocket: TrOOP, RxMOOP, and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for higher incomes
Medicare Advantage plans (MAPD)
Medicare Supplements - Medigap
Medicare plan providers
General Medicare Part D (PDP)
General Medicare
Diabetes and diabetic coverage
Your Health & Wellness
About Q1Medicare.com


Prescription Discounts for the Whole Family
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
» Compare prices at pharmacies near you.
Your drug discount card is available to you at no cost.


© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.